Heidi Cuthbert

The Star Entertainment Group (ASX:SGR) reported a $307.3 million loss in FY26, an improvement on the $427.9 million it lost in FY25.

Solana (CRYPTO:SOL) plans to activate Transaction V1 on September 9, increasing its transaction limit to 4,096 bytes.

Monash IVF Group (ASX:MVF) reported FY26 revenue of $269.5 million alongside an underlying net profit after tax of $16.1 million.

Amarin (NASDAQ:AMRN) reported new post hoc REDUCE-IT Legacy analysis data showing that patients with high adherence to icosapent ethyl experienced an approximately 29%–30% relative reduction in the primary cardiovascular endpoint compared with placebo.

Eli Lilly (NYSE:LLY) received U.S. FDA approval for an expanded indication of Mounjaro (tirzepatide) to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes at high cardiovascular risk.

Quoin Pharmaceuticals (NASDAQ:QNRX) reported positive interim results from its Phase 2/3 CL-QRX003-004 study showing QRX003 4% lotion met its primary endpoint in the first six participants with Netherton Syndrome.

US spot Ether ETFs recorded US$234.52 million in net inflows on August 27, according to SoSoValue data.

The Sandbox will repay eligible SAND holders after a bridge exploit drained 14.744 million SAND, worth about US$700,000.

Ripple (CRYPTO:XRP) Prime has launched a Delta One service for institutions, expanding into US equity derivatives.

Respiratory imaging business 4DMedical (ASX:4DX) reported a 77% increase in annual scan volume to 344,075 scans for FY26.